Log In
Print
BCIQ
Print
Print this Print this
 

Jalyn, dutasteride/tamsulosin (Duodart)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionCombination of dutasteride, a 5-alpha reductase inhibitor, and tamsulosin, an adrenergic receptor alpha 1 antagonist
Molecular Target 5-alpha reductase ; Adrenergic receptor alpha 1 (ADRA1)
Mechanism of Action5-alpha reductase inhibitor; Adrenergic receptor alpha 1 (ADRA1) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationBenign prostatic hyperplasia (BPH)
Indication DetailsTreat benign prostatic hyperplasia (BPH)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today